We performed RNA sequencing and enumerated myeloid cells within newly diagnosed, treatment-naive specimens of human IDH-mutant grade 4 astrocytoma and IDH-wildtype glioblastoma (GBM) and developed a syngeneic mouse model to compare glioma lines differing only in IDH mutation status. This evidence concerns the gene IDH1 and central nervous system cancer.